Tonix Pharmaceuticals (TNXP) News Today $31.98 -2.56 (-7.41%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$32.02 +0.04 (+0.14%) As of 06/13/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why is Tonix Pharmaceuticals Dropping Today?Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) shares have declined after the company disclosed multiple equity‐raising moves, while also adding commercial industry veteran James “Jim” Hunter to its board. Investors are weighing the dilution impact of new share offerings against the potential upside from strengthened commercial leadership. Appointment of James “Jim” Hunter—over 40 years of biopharma commercial experience—added to the Board of Directors Analyst commentary debating whether the recent pullback presents a buying opportunity Filed to raise up to $500 million in mixed securities, triggering an initial share tumble Announced a $225 million share offering, causing further downward pressure Entered into share sales and purchase agreements, leading to additional declines Pre‐market announcement of a share sale led to a nearly 20% plunge in early trading Shares fell more than 15% after filing a $500 million shelf registration Recent sell‐off prompted questions on whether it’s time to sell amid further dilution concerns Posted 1+ days agoAI Generated. May Contain Errors. TNXP Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Two Sigma Investments LP Makes New $66,000 Investment in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)Two Sigma Investments LP bought a new position in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 200,797 shares of the company's stock, valued at approximaJune 14 at 3:17 AM | marketbeat.comMillennium Management LLC Lowers Holdings in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)Millennium Management LLC trimmed its holdings in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Free Report) by 21.4% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 284,123 shares of the compJune 14 at 3:11 AM | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 2.8% - Time to Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.8% - What's Next?June 13 at 1:55 PM | marketbeat.comTonix Pharmaceuticals: Is The Recent Sell-Off A Buy Occasion?June 13 at 7:51 AM | seekingalpha.comTonix Pharmaceuticals Announces Appointment of Commercial Industry Veteran, James “Jim” Hunter, to Board of DirectorsJune 13 at 7:00 AM | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 10.1% - Here's What HappenedTonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 10.1% - Should You Sell?June 12 at 2:48 PM | marketbeat.comTonix Pharma Stock Plunges 20% Pre-market On Share Sale Announcement, But Retail’s Not PessimisticJune 12 at 2:00 PM | msn.comTonix Pharmaceuticals stock falls after announcing $225 million share offeringsJune 12 at 11:39 AM | investing.comTonix Pharmaceuticals (TNXP) Files To Raise $500 Million, Shares TumbleJune 12 at 11:17 AM | benzinga.comTonix Shares Fall After Entering Sales, Purchase AgreementsJune 12 at 8:59 AM | marketwatch.comTonix Pharmaceuticals files $500M mixed securities shelf, shares down 15%June 12 at 6:34 AM | seekingalpha.comTonix Pharma Signs Major Sales Agreements for FundingJune 11, 2025 | tipranks.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading 1.9% Higher - What's Next?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 1.9% Higher - Still a Buy?June 11, 2025 | marketbeat.comTonix Pharmaceuticals Announces Presentation at the 2025 BIO International ConventionJune 10, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 2.8% - Here's What HappenedTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 2.8% - Here's What HappenedJune 9, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Rating Increased to Hold at Wall Street ZenJune 8, 2025 | americanbankingnews.comTonix Pharmaceuticals (NASDAQ:TNXP) Upgraded to "Hold" at Wall Street ZenWall Street Zen raised Tonix Pharmaceuticals from a "sell" rating to a "hold" rating in a research report on Saturday.June 7, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 6.4% - Time to Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 6.4% Higher - Should You Buy?June 6, 2025 | marketbeat.comTonix Pharmaceuticals Announces Poster Presentation at the Annual European Congress of Rheumatology (EULAR) 2025June 5, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 2.8% - What's Next?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 2.8% - What's Next?June 4, 2025 | marketbeat.comNorthern Trust Corp Acquires New Shares in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)Northern Trust Corp acquired a new stake in shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 489,735 shares of the company's stock, valued atJune 4, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Up 10.4% - Time to Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Trading 10.4% Higher - What's Next?June 3, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.1% - What's Next?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 4.1% - Here's What HappenedJune 2, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Cut to Sell at Wall Street ZenWall Street Zen downgraded Tonix Pharmaceuticals from a "hold" rating to a "sell" rating in a report on Friday.May 31, 2025 | marketbeat.comTonix Pharmaceuticals: August PDUFA Date For Fibromyalgia Med A Risky BetMay 30, 2025 | seekingalpha.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading Down 3.6% - Here's WhyTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 3.6% - Time to Sell?May 30, 2025 | marketbeat.comZacks Small Cap Brokers Boost Earnings Estimates for TNXPTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Free Report) - Zacks Small Cap upped their Q2 2025 EPS estimates for Tonix Pharmaceuticals in a research report issued on Wednesday, May 28th. Zacks Small Cap analyst D. Bautz now anticipates that the company will post earnings of ($10.73) per shMay 30, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 9.1% - Should You Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 9.1% - Here's WhyMay 29, 2025 | marketbeat.comJane Street Group LLC Purchases 1,635,119 Shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)Jane Street Group LLC boosted its position in shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Free Report) by 5,932.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,662,682 shares of the company's stock aftMay 29, 2025 | marketbeat.comWhat's Going On With Tonix Pharmaceuticals Stock?May 28, 2025 | benzinga.comTonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Down 6% - Time to Sell?Tonix Pharmaceuticals (NASDAQ:TNXP) Shares Down 6% - Here's WhyMay 28, 2025 | marketbeat.comTNXP: Preparations Continue for Potential Commercial Launch of TNX-102 SL in Fibromyalgia…May 28, 2025 | finance.yahoo.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 9% - Here's WhyTonix Pharmaceuticals (NASDAQ:TNXP) Shares Up 9% - What's Next?May 27, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Trading 2.8% Higher - Still a Buy?Tonix Pharmaceuticals (NASDAQ:TNXP) Stock Price Up 2.8% - Here's WhyMay 25, 2025 | marketbeat.comPoint72 Asset Management L.P. Makes New $526,000 Investment in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)Point72 Asset Management L.P. purchased a new position in shares of Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 1,596,344 shares of the company'May 25, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Upgraded at Wall Street ZenWall Street Zen upgraded Tonix Pharmaceuticals from a "sell" rating to a "hold" rating in a research note on Thursday.May 24, 2025 | marketbeat.comTonix Pharmaceuticals Announces Presentation at the A.G.P. Annual Healthcare Company ShowcaseMay 22, 2025 | globenewswire.comTonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress ReactionMay 21, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Pass Above 200-Day Moving Average - Here's WhyTonix Pharmaceuticals (NASDAQ:TNXP) Share Price Crosses Above 200-Day Moving Average - Here's What HappenedMay 17, 2025 | marketbeat.comTonix Pharmaceuticals (TNXP) Stock Surges Following Insider Buying And Q1 ResultsMay 16, 2025 | benzinga.comInsider Buying: Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) CEO Purchases 4,000 Shares of StockMay 16, 2025 | insidertrades.comTonix Pharma Stock Soars After Roping In Former Celgene Corp Executive Joseph Hand: Retail Gets More PositiveMay 15, 2025 | msn.comTonix Pharmaceuticals (NASDAQ:TNXP) Releases Earnings Results, Beats Expectations By $0.39 EPSTonix Pharmaceuticals (NASDAQ:TNXP - Get Free Report) issued its earnings results on Monday. The company reported ($2.84) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($3.23) by $0.39. Tonix Pharmaceuticals had a negative net margin of 1,197.86% and a negative return on equity of 163.95%.May 14, 2025 | marketbeat.comTonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq. ...May 14, 2025 | gurufocus.comTonix Pharmaceuticals (TNXP) Appoints New General Counsel and EVP of Operations | TNXP Stock NewsMay 14, 2025 | gurufocus.comTonix Pharma Appoints New General Counsel and EVPMay 14, 2025 | tipranks.comTonix Pharmaceuticals Announces Appointment of Joseph Hand, Esq., as General Counsel and Executive Vice President of OperationsMay 14, 2025 | globenewswire.comTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational HighlightsMay 13, 2025 | finanznachrichten.deTonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights | ...May 12, 2025 | gurufocus.comTonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational HighlightsMay 12, 2025 | gurufocus.com Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address TNXP Media Mentions By Week TNXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNXP News Sentiment▼0.690.89▲Average Medical News Sentiment TNXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNXP Articles This Week▼165▲TNXP Articles Average Week Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Aurinia Pharmaceuticals News Wave Life Sciences News Niagen Bioscience News Mineralys Therapeutics News Arcus Biosciences News Spyre Therapeutics News Akebia Therapeutics News Enliven Therapeutics News CureVac News Avadel Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNXP) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TNXP Stock Free TNXP Stock Alerts